Delayed
Nasdaq
11:56:13 2024-06-05 am EDT
|
5-day change
|
1st Jan Change
|
6.56
USD
|
-6.55%
|
|
-15.86%
|
-91.37%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
3.606
|
40.1
|
15.85
|
5.026
|
1.625
|
4.307
|
-
|
Enterprise Value (EV)
1 |
3.606
|
40.1
|
15.85
|
5.026
|
1.625
|
4.307
|
4.307
|
P/E ratio
|
-0.31
x
|
-1.55
x
|
-1.78
x
|
-0.18
x
|
-0.12
x
|
-0.32
x
|
-0.65
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
5.23
x
|
67.5
x
|
26.2
x
|
3.22
x
|
0.62
x
|
1.49
x
|
1.26
x
|
EV / Revenue
|
5.23
x
|
67.5
x
|
26.2
x
|
3.22
x
|
0.62
x
|
1.49
x
|
1.26
x
|
EV / EBITDA
|
-0.56
x
|
-4.76
x
|
-1.59
x
|
-0.48
x
|
-0.14
x
|
-0.32
x
|
-0.3
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
1.49
x
|
0.89
x
|
-
|
-
|
2.54
x
|
-0.43
x
|
Nbr of stocks (in thousands)
|
0.12
|
1.28
|
1.24
|
2.6
|
21.3
|
613.5
|
-
|
Reference price
2 |
29,800
|
31,400
|
12,838
|
1,936
|
76.28
|
7.020
|
7.020
|
Announcement Date
|
3/26/20
|
3/22/21
|
3/25/22
|
3/29/23
|
3/27/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
0.689
|
0.594
|
0.606
|
1.561
|
2.627
|
2.9
|
3.406
|
EBITDA
1 |
-6.487
|
-8.421
|
-9.97
|
-10.37
|
-11.7
|
-13.41
|
-14.49
|
EBIT
1 |
-6.594
|
-8.504
|
-10.62
|
-11.34
|
-
|
-13
|
-12.4
|
Operating Margin
|
-957.04%
|
-1,431.65%
|
-1,752.48%
|
-726.14%
|
-
|
-448.28%
|
-364.12%
|
Earnings before Tax (EBT)
1 |
-4.797
|
-
|
-8.775
|
-12.04
|
-
|
-10.7
|
-12.3
|
Net income
1 |
-7.5
|
-16.59
|
-8.775
|
-16.49
|
-8.285
|
-10.7
|
-14.19
|
Net margin
|
-1,088.53%
|
-2,793.6%
|
-1,448.02%
|
-1,056.31%
|
-315.38%
|
-368.97%
|
-416.69%
|
EPS
2 |
-96,400
|
-20,200
|
-7,200
|
-10,934
|
-626.0
|
-21.99
|
-10.78
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/26/20
|
3/22/21
|
3/25/22
|
3/29/23
|
3/27/24
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
0.165
|
0.129
|
0.24
|
0.426
|
0.765
|
0.539
|
0.508
|
0.678
|
0.902
|
0.687
|
0.7
|
0.7
|
0.8
|
0.786
|
0.7725
|
EBITDA
1 |
-2.394
|
-2.681
|
-2.58
|
-2.266
|
-2.6
|
-3.219
|
-3.056
|
-3.151
|
-2.275
|
-2.777
|
-3.028
|
-3.656
|
-4.005
|
-3.54
|
-3.554
|
EBIT
1 |
-2.591
|
-2.88
|
-2.783
|
-2.793
|
-2.881
|
-3.557
|
-3.464
|
-3.614
|
-
|
-3.197
|
-3.3
|
-3.3
|
-3.3
|
-3.2
|
-3.2
|
Operating Margin
|
-1,570.3%
|
-2,232.56%
|
-1,159.58%
|
-655.63%
|
-376.6%
|
-659.93%
|
-681.89%
|
-533.04%
|
-
|
-465.36%
|
-471.43%
|
-471.43%
|
-412.5%
|
-407.12%
|
-414.24%
|
Earnings before Tax (EBT)
1 |
-1.6
|
-2.845
|
-2.512
|
-2.724
|
-3.958
|
-0.293
|
-2.455
|
-3.19
|
-
|
-0.886
|
-3.3
|
-3.3
|
-3.3
|
-3.1
|
-3.2
|
Net income
1 |
-1.6
|
-2.845
|
-2.512
|
-2.724
|
-8.408
|
-0.293
|
-2.455
|
-3.19
|
-2.321
|
-0.886
|
-3.3
|
-3.3
|
-3.3
|
-3.1
|
-3.2
|
Net margin
|
-969.7%
|
-2,205.43%
|
-1,046.67%
|
-639.44%
|
-1,099.08%
|
-54.36%
|
-483.27%
|
-470.5%
|
-257.32%
|
-128.97%
|
-471.43%
|
-471.43%
|
-412.5%
|
-394.4%
|
-414.24%
|
EPS
2 |
-1,400
|
-2,400
|
-2,000
|
-2,200
|
-4,334
|
-26.00
|
-122.0
|
-162.0
|
-18.00
|
-10.00
|
-5.310
|
-5.290
|
-5.220
|
-4.870
|
-5.010
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/25/22
|
5/13/22
|
8/12/22
|
11/14/22
|
3/29/23
|
5/15/23
|
8/8/23
|
11/14/23
|
3/27/24
|
5/13/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
-
|
21,020
|
14,348
|
-
|
-
|
2.760
|
-16.40
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
0.15
|
0.36
|
3.74
|
-
|
-
|
0.6
|
1
|
Capex / Sales
|
21.34%
|
60.61%
|
617%
|
-
|
-
|
20.69%
|
29.36%
|
Announcement Date
|
3/26/20
|
3/22/21
|
3/25/22
|
3/29/23
|
3/27/24
|
-
|
-
|
Last Close Price
7.02
USD Average target price
70
USD Spread / Average Target +897.15% Consensus |
1st Jan change
|
Capi.
|
---|
| -91.35% | 4.31M | | -5.29% | 11.09B | | -1.95% | 8.56B | | +39.51% | 5.62B | | -26.26% | 4.41B | | +7.42% | 3.41B | | -16.67% | 2.6B | | -12.01% | 2.07B | | -13.56% | 1.92B | | -29.81% | 1.63B |
Medical Devices & Implants
|